Healthcare Success

JANUARY 25, 2023

However, these numbers escalated in 2020, along with the COVID-19 pandemic. Negative or angry emotions According to her survey of 70,000 “The Mighty” readers and community members, the number of people choosing anger as their top emotion more than doubled from March to September 2020— rising from 20% to 45%. How did we get here?

Patients 105

Patients Healthcare Healthcare Management 105

pharmaphorum

DECEMBER 1, 2022

Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials. A 2018 NIH survey found that patients felt clinical trial participation to be inconvenient and burdensome, and nearly half (49.0%) said it disrupted their daily routine.

Patients 106

Patients Transportation Retail Recruitment 106

pharmaphorum

SEPTEMBER 14, 2022

and the EU in order to examine the perception of clinical research one year into the pandemic and attitudes toward trial participation, including the reasons patients enrol in clinical trials. Leveraging patient perspectives. Interest by demographics. Opportunities for change.

Recruitment 92

Recruitment Patients Media Management 92

Healthcare Success

MAY 9, 2022

The QR code allows hospitals and healthcare providers to satisfy this need with immediate physician-patient interaction and engagement – all through smartphones and tablets. . In this blog post, you’ll learn: Why QR codes have made a comeback, When to use them, And, 8 ways to improve the patient experience and drive leads with QR codes. .

Leads 109

Leads Patients Healthcare Provider Healthcare 109

Pharmaceutical Technology

FEBRUARY 2, 2023

It is claimed to be the only HIF-PHI approved in the country that offers a new oral treatment option for adult patients on dialysis with anaemia of CKD. We are proud to have developed Jesduvroq as a new oral treatment where there is a patient desire for more options.” dL) for the patients.

Food and Drug Administration 105

Food and Drug Administration FDA Safety Food 105

pharmaphorum

OCTOBER 26, 2022

And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community. We try to have a very long-term orientation because we believe that aligns our objectives very well with the objectives of society and the patients we serve, and it makes us a stable business.”.

Patients 82

Patients Pharma Consulting Transportation 82

World of DTC Marketing

DECEMBER 23, 2020

DTC marketers who believe that DTC is essentially the same as before the pandemic are failing to recognize significant shifts in patient behavior regarding prescription drugs. In an era of a pandemic, are psoriasis patients really going to ask for a drug that may compromise their immune system? What are other patients saying about it?

Prescription 249

Prescription Doctors Side effects Marketing 249

World of DTC Marketing

OCTOBER 21, 2020

2020 trend concept. Hand flip wood cube change year 2019 to 2020. 10en : The most consumed pages on most pharma websites is safety information and pages that offer co-pay cards as people try to save money on Rx’s. In my opinion, this is due to pharma being sold on programmatic and the lack of investment in creative.

Media 287

Media Pharma Medical Safety 287

Pharmaceutical Technology

APRIL 3, 2023

Eisai and the National Cancer Center have signed an agreement to partner on investigator-initiated clinical research for the anti-cancer agent, tazemetostat (Tazverik Tablets 200 mg), based on the Patient-Proposed Healthcare Services system.

Insurance 98

Insurance Government Safety Patients 98

European Pharmaceutical Review

JANUARY 25, 2024

Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. 3 Moreover, digital platforms can be tailored to the needs of patients and healthcare professionals, offering accessible, trustworthy and up-to-date information on medicines precisely when required.

Healthcare 80

Healthcare Healthcare Electronics Safety 80

PM360

SEPTEMBER 15, 2022

The term “patient centricity” has been around for over a decade, and since its first utterance the buzzword has been praised, dissected, criticized, and everything in between. The concept has always been worthwhile, but people within and outside of the industry have wondered whether the industry was truly becoming more patient centric?

Patients 98

Patients Healthcare Healthcare Marketing 98

Pharmaceutical Technology

APRIL 21, 2023

Nonetheless, the agency did not require further efficacy and safety data in the application. The type II FLT3 inhibitor could also be used as continuation monotherapy post consolidation in this set of adult patients. Over 474,500 cases of leukemia were reported across the world in 2020, per the company’s April 20 press release.

Food and Drug Administration 98

Food and Drug Administration FDA Safety Prescription 98

pharmaphorum

JUNE 22, 2022

Pfizer has harnessed the expertise of health data specialist Truveta to provide close monitoring of safety and other signals for its products, including COVID-19 vaccine Comirnaty, almost in real-time. Using the resource, Pfizer can “learn directly from de-identified patient data at an unprecedented pace and scale,” she added.

Pharma 97

Pharma Electronics Safety Medical 97

European Pharmaceutical Review

MAY 2, 2023

3 With greater scientific understanding of cancer, the industry has made significant progress in developing innovative medicines to help patients. However, access to these medicines is not close to meeting patient demand, creating inequalities in the health prospects of those diagnosed with cancer. 1,2 In the EU, an estimated 2.7

Patients 98

Patients Medicine Marketing Medical 98

European Pharmaceutical Review

JANUARY 29, 2024

Overall, the authors summarised that the enhanced sensitivity improves safety assessments for volatiles in medical devices. The paper discussed the detection of volatile extractables released during the clinical use of medical devices.

Food and Drug Administration 78

Food and Drug Administration Medical Safety Food 78

Pharma Leaders

JUNE 27, 2023

An oral inhibitor of hypoxia-inducible factor prolyl hydroxylase, daprodustat is intended for usage in adult patients who are on chronic maintenance dialysis. The company is developing the therapy as an oral treatment option for CKD patients with anaemia. CKD is characterised by gradual kidney function loss.

Food and Drug Administration 52

Food and Drug Administration Medicine Food Safety 52

Healthcare Success

MAY 9, 2022

The QR code allows hospitals and healthcare providers to satisfy this need with immediate physician-patient interaction and engagement – all through smartphones and tablets. . In this blog post, you’ll learn: Why QR codes have made a comeback, When to use them, And, 8 ways to improve the patient experience and drive leads with QR codes. .

Leads 52

Leads Patients Healthcare Provider Healthcare 52

pharmaphorum

AUGUST 24, 2022

The biotech has confirmed it will not launch the biosimilar until March 2025 however, honouring the terms of its 2020 agreement with Alexion that resolved litigation over the validity of patents covering Soliris (eculizumab) in the US.

Safety 90

Safety Sales Patients FDA 90

Pharma Marketing Network

JANUARY 6, 2021

Throughout the year 2020, pharma marketers were forced to explore new strategies in order to keep up with the many evolving trends. Tools that help people track their health, including apps, wearables, and patient portals will be used more than ever in 2021. Trend #3: Relationships Despite Digital Congestion.

Marketing 98

Marketing Pharma Media Safety 98

World of DTC Marketing

JANUARY 8, 2021

Moderna, maker of one of only two vaccines granted emergency authorizations to prevent COVID-19 in the US, has been shamed with a 2020 “Shkreli Award” by the Lown Institute, a healthcare think tank. However, in vaccines, cut corners could compromise patient safety. So far the winners are Pfizer and Moderna.

Government 266

Government Safety FDA Pharma 266

Pharmaceutical Technology

JUNE 28, 2022

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended granting approval for AstraZeneca and Merck’s (MSD outside the US and Canada) Lynparza (olaparib) as adjuvant therapy for high-risk early breast cancer patients.

Safety 64

Safety Medicine Patients Medical 64

pharmaphorum

AUGUST 23, 2022

France’s BrainVectis, a subsidiary of Bayer’s Asklepios BioPharma (AskBio) unit, has been given the green light by regulators in France to start dosing patients with its gene therapy candidate for devastating neurodegenerative disorder Huntington’s disease.

Safety 104

Safety Biopharma Patients 104

Pharmaceutical Technology

NOVEMBER 9, 2022

Despite their potential multi-million-dollar sticker price, if haemophilia treatments by BioMarin and CSL Behring prove durable, they could help patients save money compared to current treatments, experts note. A previous October 2020 report concluded that longer-term safety and efficacy were needed to update health-benefit price benchmarks.

Safety 111

Safety Pharmaceutical Patients Medicine 111

pharmaphorum

JANUARY 4, 2023

More than 30 years after it was first formed, Geron is on the cusp of bringing its first product to market, after imetelstat hit the mark in a phase 3 trial in patients with myelodysplastic syndromes (MDS). “True innovation is a lot harder than it sounds,” he said. “And this isn’t the ultimate victory lap today.

Safety 98

Safety Marketing Patients Pharma 98

Pharmaceutical Technology

JANUARY 23, 2023

The term LN refers to a major predictor of poor prognosis in SLE patients, with inflammation of the kidney that encompasses diverse patterns of renal disease, including glomerular and vascular pathology. In previous years, Benlysta has managed to grow the lupus market in terms of value, having generated approximately $492.9m

Marketing 111

Marketing Safety Patients Pharmaceutical 111

European Pharmaceutical Review

NOVEMBER 20, 2023

“This state-of-the-art parenteral site with the latest technology will enable us to continue to deliver medicines with safety first and quality always around the world,” stated Edgardo Hernandez, Executive Vice President and President of Eli Lilly’s manufacturing operations.

Manufacturing 81

Manufacturing Medicine Biopharma Engineering 81

European Pharmaceutical Review

AUGUST 11, 2023

Crizanlizumab is a once-a-month, humanised monoclonal antibody infusion, indicated for the prevention of recurrent vaso‑occlusive crises (pain crises) in sickle cell disease patients aged 16 years and above. Adakveo (crizanlizumab) received conditional authorisation by the EC in October 2020.

Marketing 81

Marketing Food and Drug Administration Medicine FDA 81

pharmaphorum

NOVEMBER 2, 2022

With the merger now completed, Norstella becomes a $5 billion group with 1,500 employees across the five business brands with the overarching objective of guiding life sciences companies through the drug development process so patients can get access to therapies more quickly. Photo by Edge2Edge Media on Unsplash.

Pharma 81

Pharma Marketing Patients Consulting 81

World of DTC Marketing

NOVEMBER 1, 2021

SUMMARY: According to eMarketer, “in 2020, spending on digital advertising in the healthcare and pharma industry will grow by 14.2% What’s missing, however, is the need to get patients back into their doctor’s offices for treatments and bothersome health issues. to reach $9.53 this year).

Doctors 227

Doctors Pharma Retail Electronics 227

Pharmaceutical Technology

OCTOBER 13, 2022

Under the contract, the company will collect the long-term clinical data from patients with Covid-19 in Peru and Argentina, where the C001-2020-01 trial was carried out. The data will show the therapy’s potential effectiveness for the treatment of the long-term effects of respiratory distress caused after Covid-19.

Safety 72

Safety Patients Pharmaceutical 72

World of DTC Marketing

AUGUST 12, 2022

In the past 12 months, PhRMA and closely allied groups spent at least $57 million — $19 million of it since July — on TV , cable , radio , and social media ads opposing price negotiations, according to monitoring by the advocacy group Patients for Affordable Drugs. First, let’s clarify how the bill saves taxpayers billions.

Pharma 255

Pharma Retail Pharmaceutical manufacturing Pharmaceutical 255

pharmaphorum

NOVEMBER 22, 2022

Some patients will be able to continue to receive the drug via a compassionate use programme. GSK had great expectations for Blenrep, which was approved in 2020 for multiple myeloma patients who have received at least four prior therapies – including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent.

Marketing 104

Marketing FDA Patients Safety 104

Clarivate

OCTOBER 28, 2021

That’s why trademark analysts also assess for patient safety. It can be a tricky business, and an important one not just for commercial reasons, but also for patient safety. The brand name chosen for a vaccine or drug is more than a commercial matter. Get the full story. Coming together for a shared cause.

Prescription 98

Prescription Safety Leads Medicine 98

World of DTC Marketing

MAY 19, 2021

SUMMARY: “You’re spending all this money to make sure you make money rather than spending money to… help patients,” the California congresswoman told AbbVie’s, Richard Gonzalez. According to CNBC “AbbVie workers say they worry that the company is putting profits ahead of safety and the health of its U.S.

Pharma 181

Pharma Prescription Patients Safety 181

Pharmaceutical Technology

JULY 4, 2022

In June 2020, Brii Bio exercised its option and acquired the exclusive rights for the further development and marketing of BRII-835 (VIR-2218) in Greater China. We are confident that this new asset further strengthens our HBV pipeline by providing more potent and assured reduction of HBsAg in all patients.

Safety 111

Safety Medical Marketing Sales 111

European Pharmaceutical Review

DECEMBER 28, 2023

Following their introduction, these therapies have moved to early lines of treatment, but unfortunately, a significant number of patients are not cured with these approaches. As a result, when the patient’s lymphoma relapses after treatment with chemotherapy, BV and CPIs, there are no effective treatment alternatives for these patients.

Food and Drug Administration 84

Food and Drug Administration Patients Safety Medical science 84

Pharma Marketing Network

JULY 19, 2023

This could include sponsoring research into new drugs and treatments, providing educational resources about health conditions, or supporting patient care programs. This could help to improve the lives of patients and make a real difference in the world. This could help to ensure that everyone has access to the care they need.

Pharmaceutical 98

Pharmaceutical Healthcare Healthcare Education 98